Coronavirus (COVID-19) Response • Have you downloaded COVIDWISE, Virginia's COVID-19 exposure notification app? Add your phone to the fight here. For up-to-date information, assistance, and resources from across state government, click here.
WHEREAS, Alpha-1 Antitrypsin Deficiency (Alpha-1) is one of the most common serious hereditary disorders in the world that can result in life threatening lung disease; and
WHEREAS, Alpha-1 is often misdiagnosed in both children and adults as asthma or liver disease; and
WHEREAS, Alpha-1 has been identified in virtually all populations, but its prevalence varies by population, this disorder affects but largely about 1 in 1,500 to 3,500 individuals with European ancestry; and
WHEREAS, people with Alpha-1 develop the first signs and symptoms of lung disease between the ages of twenty and fifty; and
WHEREAS, it is important to increase awareness and detection of this serious hereditary and misdiagnosed disorder; and
WHEREAS, during the month of November, a nationwide awareness campaign will take place throughout the country to educate the public as well as the medical community on Alpha-1 detection and treatment for those affected by this condition;
NOW, THEREFORE, I, Ralph S. Northam, do recognize November 2018 as ALPHA-1 ANTITRYSIN DEFICIENCT AWARENESS MONTH in our COMMONWEALTH OF VIRGINIA, and I call this observance to the attention of all our citizens.